Verdict
Hone Health targets men's hormone optimisation (testosterone, semaglutide, peptides) with an at-home blood-draw model. GLP-1 added in 2024 as part of the metabolic-optimisation product line. Strong for the testosterone+GLP-1 stack; less obesity-medicine depth than Form Health.
Pros
- Stacks compounded tirzepatide with testosterone for men's hormone optimization.
- At-home blood draws included in the lab cadence.
- $25/mo basic membership for member pricing on medications.
- Strong customer support in member feedback.
- Cancel anytime, no annual commitment.
Cons
- Pricier all-in than cash-pay-only GLP-1 programs.
- Markets non-FDA-approved peptides beyond GLP-1, broader regulatory exposure.
- Less women-friendly positioning, the brand is built for men.
- Compounded only, no branded Wegovy or Zepbound pathway.
- Less obesity-medicine depth than Form Health.
- At-home blood draws
- Integrated testosterone + GLP-1 model
- Strong customer support
- Pricier than cash-pay-only GLP-1 programs
- Markets non-FDA-approved peptides which may attract regulatory attention
- Less women-friendly positioning
Best for
- Men interested in combined hormone-optimisation and weight loss. Patients who want at-home blood draws and broader metabolic protocols beyond standard obesity care.
Not for
- Patients seeking obesity-medicine specialisation, women's-specific needs or the cheapest cash-pay path.
Pricing
Basic membership $25/mo (labs every 6 months + member pricing on meds). Premium $149/mo (full labs + physician consults). Liraglutide $160/mo separate; initial blood draw $65.
Lock-in & cancellation
Month-to-month
Cancel anytime; no annual commitment.
How to cancel: Month-to-month, cancel anytime, no annual commitment; an initial blood draw (~$65) is required to start.
Medication options
Compounded from named 503A pharmacy partner. Includes testosterone where indicated.
The FDA officially removed semaglutide from the drug-shortage list in February 2025, which narrowed the legal basis for routine 503A compounding of exact-copy semaglutide. Hone Health addresses this by using a personalized-formulation model (the compound includes an additional active ingredient like vitamin B12) which is legally distinct from the FDA-approved product. The active GLP-1 molecule is the same; the regulatory framing is different. Some state pharmacy boards have tightened oversight in 2025-2026. For the full background see our compounded vs FDA-approved breakdown.
FDA-approved branded
- None offered
503A-compounded
- Compounded semaglutide
- Compounded tirzepatide
Other medications
- Testosterone
- Other off-label peptides
- Hone markets compounded peptides beyond GLP-1; the broader peptide-marketing landscape has higher 2025-2026 regulatory exposure than GLP-1 alone
Onboarding experience
Time to first prescription: 7 days.
Consultation type: Video visit + at-home blood draw.
Requirements: Lab work, medical history, ID.
Member feedback
Men's-focused metabolic platform with positive feedback on the integrated hormone+weight model. Compounded peptide offerings beyond GLP-1 raise some regulatory questions.
What works
- At-home blood draws
- Integrated testosterone + GLP-1 model
- Strong customer support
What to watch
- Pricier than cash-pay-only GLP-1 programs
- Markets non-FDA-approved peptides which may attract regulatory attention
- Less women-friendly positioning
How we scored Hone Health
Five dimensions, ten points each, weighted equally. Overall is the simple average.
Transparency
Terms
Experience
Options
Outcomes
Frequently asked questions
Is Hone women-friendly?
Alternatives to Hone Health
If Hone Health isn't the right fit, here are three programs we'd consider as next options:
Learn the category before you commit
Four pieces we'd read before signing up for any GLP-1 telehealth program, Hone Health included:
